TSHA·877619106·US·equity·Healthcare - Biotechnology-Activist
TSHA (TAYSHA GENE THERAPIES INC) is held by 112 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($105.3M), GOLDMAN SACHS GROUP INC ($100M), Avoro Capital Advisors LLC ($97M). Net institutional sentiment: Mixed.
See how TSHA's score breaks down across 4 SEC sources
Showing 1-20 of 126
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer